TMCnet News
Research and Markets: Global Uterine Cancer Clinical Trials Review, H2, 2013DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/pqpbsc/uterine_cancer) has announced the addition of the "Global Uterine Cancer Clinical Trials Review, H2, 2013" report to their offering. Our clinical trial report provides data on the Uterine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trialsfor the key drugs for treating Uterine Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope
Key Topics Covered: Table of Contents List of Tables Introduction Uterine Cancer Report Guidance Clinical Trials by Region Clinical Trials by Country Top Five Countries Contributing to Clinical Trials in Asia-Pacific Top Five Countries Contributing to Clinical Trials in Europe Top Countries Contributing to Clinical Trials in North America Top Five Countries Contributing to Clinical Trials in Middle East and Africa Top Five Countries Contributing to Clinical Trials in Central and South America Clinical Trials Prominent Sponsors Top Companies Participating in Uterine Cancer Therapeutics Clinical Trials Clinical Trial Overview of Top Companies Appendix For more information visit http://www.researchandmarkets.com/research/pqpbsc/uterine_cancer
|